Clinical Report: 1α,25-Dihydroxyvitamin D3 Influences T Cell Activation
Overview
This study investigates the effects of 1α,25-dihydroxyvitamin D3 on human T cell activation and immune checkpoint mechanisms. Findings indicate that this vitamin D metabolite modulates IFN-γ production and immune checkpoint gene expression in CD8+ T cells.
Background
Vitamin D plays a crucial role in immune regulation, particularly in T cell function. Understanding how 1α,25-dihydroxyvitamin D3 influences T cell responses is essential.
Data Highlights
Parameter
Result
IFN-γ Expression
Reduced with 1,25(OH)2 vitamin D
PDCD1 mRNA Expression
Increased
CTLA4 mRNA Expression
Increased
CD8+ T-cell PD-1 Expression
Increased at 10 nM
CD8+ T-cell CTLA-4 Expression
Increased at 100 nM
Degranulation Markers
Decreased
Key Findings
1,25(OH)2 vitamin D reduced IFN-γ expression and secretion in T cells.
Increased PDCD1 and CTLA4 mRNA expression was observed with vitamin D treatment.
CD8+ T cells showed increased PD-1 and CTLA-4 expression at specific doses of vitamin D.
No significant changes were detected in TIM-3 or TIGIT expression.
CD4+ T cells did not show significant modulation of immune checkpoint molecules.
IL-22 secretion was reduced in CD4+ T cells following treatment.
Clinical Implications
The modulation of T cell activation and immune checkpoint pathways by 1,25(OH)2 vitamin D is noted. Further research is required to explore the implications of these findings.
Conclusion
This study highlights the immunomodulatory effects of 1,25(OH)2 vitamin D on human CD8+ T cells.
by Lisa Isdraele Romano, Ilenia Aversa, Antonio Abatino, Costanza Maria Cristiani, Giulio Cesare Antico, Debora Gentile, Caterina Giordano, Emilio Straface, Michael Marrano, Elvira Angotti, Camillo Palmieri, Raffaella Gallo, Giuseppe Fiume
